← Back to headlines
European Medicines Agency Approves Flexible Storage for Semaglutide
The European Medicines Agency (EMA) has approved updated conditions for injectable semaglutide, used for obesity treatment, allowing it to be stored for up to 48 hours at temperatures up to 30°C during the final stage of delivery to patients.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Oldest Known Plague Outbreak Discovered in Siberia Dating Back 5,500 Years
just now
Extreme Training: What Heat Training Does to the Body
just now
Typhoon Inday and Monsoon Rains Threaten Western Visayas with Flooding
just now
Philippines expands family planning access through health worker training
just now